Letters to the Editor

A founder heterozygous mutation in Methyl-CpG binding domain protein 4 (MBD4) prevalent among Israeli Christian Arabs predisposes to increased mutagenesis

Weizmann Institute of Science, Rehovot
Weizmann Institute of Science, Rehovot
Weizmann Institute of Science, Rehovot
Mayo Clinic Rochester, MN, USA; Nazareth Hospital EMMS, Nazareth
Weizmann Institute of Science, Rehovot
Weizmann Institute of Science, Rehovot
Weizmann Institute of Science, Rehovot
Weizmann Institute of Science, Rehovot
Haematologica Early view Sep 4, 2025 https://doi.org/10.3324/haematol.2025.287690